Clinical Trial Update: Small Trial of Alendronate Impact on the Reservoir of HIV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by NIAID is investigating whether alendronate can impact the HIV reservoir; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 2 | Status: NOT_YET_RECRUITING